Search

everythinglearnresearchcommunity

for

Search:↓

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

TrichoScan is reliable for counting and measuring hair density but may not accurately assess hair types in women with hair loss.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Older patients sticking to their prostate medication saw lasting health benefits.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Not taking prescribed medications properly can lead to higher death rates from unrelated health conditions.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Hair transplant surgeons should also focus on their patients' overall health, including regular check-ups and screening for common health issues.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Finasteride treats hair loss and reduces prostate cancer risk.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Finasteride may improve prostate cancer treatment outcomes.

Minoxidil can reduce functions related to androgen receptors.

Baldness (androgenic alopecia) could be a risk factor for prostate cancer.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Finasteride improves prostate cancer detection in PSA test.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Urinary PSA could be an early marker for enlarged prostate.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.